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R37Growth Control: Myc and Yorkie Get
ConnectedRecent work shows that the transcriptional coactivator Yorkie, which is
negatively regulated by the Hippo tumor suppressor pathway, promotes the
transcription of the proto-oncogene Myc and requires Myc function to drive
growth. In turn, Myc keeps the concentration of Yorkie in check via negative
feedback regulation.Hugo Stocker
Genetic analyses in the model
organism Drosophila melanogaster
have revealed key players in growth
control, such as the insulin/insulin-like
growth factor signaling (IIS)/target of
rapamycin (TOR) pathway, the Hippo
tumor suppressor pathway, and the
proto-oncoprotein dMyc. Whereas
IIS/TOR signaling controls cellular
growth and cell size in accordance
with the nutritional status [1], Hippo
signaling restricts proliferation by
controlling cell-cycle progression,
apoptosis, and cellular growth [2].
Hippo pathway activity culminates
in the phosphorylation and nuclear
exclusion of the transcriptional
coactivator Yorkie (Yki), thereby
hindering it from inducing the
expression of target genes that inhibit
apoptosis (e.g., Diap1), stimulate
cell-cycle progression (e.g., CycE),
and promote cellular growth
(e.g., the microRNA bantam) [2].
The proto-oncoprotein and
transcription factor dMyc induces
cellular growth by increasing the
expression of numerous target genes,
many of which promote ribosome
biogenesis [3,4]. However, the signals
dictating where, when and at which
levels dMyc is expressed have
remained largely enigmatic. Two recent
studies now reveal that dMyc is a target
gene of Yki [5,6]. Furthermore, negative
feedback regulation from dMyc to Yki
is proposed to balance growth [5].
dMyc has emerged as a key player in
cell competition where weak cells
(‘losers’) get eliminated by apoptosis
when surrounded by fitter cells
(‘winners’). It has been demonstrated
that the survival decision depends on
differences in dMyc levels between
cell populations: cells with high
dMyc expression will outcompete
neighbors with less dMyc protein [7,8].
Loss-of-function mutations in genes
encoding Hippo pathway members
have been shown to counteract cellcompetition [9] (although this study
used a different experimental system
to induce cell competition). Apparently,
the increased Yki activity in these
mutants is sufficient to overcome the
death signals imposed by fitter
surrounding cells. However, it has been
unclear whether the induction of the
caspase inhibitor Diap1 by Yki would
simply block the induction of apoptosis
and thereby keep loser cells alive, or
whether there is a more intimate
relationship between cell competition
and Hippo signaling. To clarify this
issue, the groups of Daniela Grifoni and
Laura Johnston have now investigated
connections between dMyc and the
Hippo pathway [5,6].
Both teams used sophisticated
genetic tools to generate mosaic
animals consisting of patches of
genotypically different cells, thus
enabling them to investigate the
consequences of the juxtaposition
of cells with manipulated dMyc and/or
Hippo signaling activities in the context
of a growing epithelium. Most of the
analyses were carried out in wing
imaginal discs — single-cell layered
epithelia that will eventually
differentiate into the wings of the adult
fly. The discs were typically dissected
from third instar larvae to visualize the
growth behavior of the genetically
manipulated cell populations.
Clones of cells with high Yki activity
(e.g., by overexpression of Yki)
displayed characteristics of winner
cells: not only did they grow larger,
but they also impacted on the growth
capacity of the neighboring wild-type
cells (by non-autonomously inducing
apoptosis). Conversely, cells lacking
Yki grew very poorly, and their
neighbors performed better than
control cells. Since these effects were
reminiscent of the consequences of
elevated and reduced dMyc levels,
respectively, the authors analyzed
dMyc levels in the clones. They noticed
an increase in dMyc protein levels that
coincided with high Yki activity and,conversely, a reduction in the amounts
of dMyc in situations where Yki activity
was lowered, suggesting that dMyc
expression is under the control of Yki.
Expression analyses by mRNA in situ
hybridization and by using reporter
genes (transposon insertions in the
diminutive (dm; dMyc) locus) revealed
that dMyc is transcriptionally
controlled by Yki. More precisely,
the co-activator Yki needs to team up
with Scalloped (Sd), a TEAD/TEF family
transcription factor, to induce dMyc
transcription in the pouch region of
the wing imaginal disc, because RNA
interference against sd abolished
Yki’s capacity to induce dMyc in that
region. In fact, both groups identified
putative Sd-binding sites in the
diminutive/dMyc locus, and chromatin
immunoprecipitation experiments
performed by Neto-Silva and
colleagues [5] revealed that some
of these sites were indeed bound
by Sd and Yki.
Is the induction of dMyc expression
required for Yki’s growth-promoting
effect? Yki-overexpressing cells that
were concomitantly mutant for dMyc
failed to overgrow and to outcompete
their neighbors, suggesting that dMyc
is necessary for the Yki-mediated
supercompetitive behavior. However,
dMyc expression is not sufficient: the
growth of clones of yki mutant cells
could not be restored by the
expression of dMyc, either alone
or in combination with the caspase
inhibitors Diap1 or p35. Thus,
additional target genes of Yki-
containing transcriptional complexes
are required to promote growth.
Ziosi and colleagues [6] tested how
Yki-overexpressing cells (i.e. cells with
increased amounts of dMyc) behaved
when facing cells with even higher
dMyc levels. In this scenario, the
Yki-overexpressing cells failed to
outcompete their neighbors, and the
resulting clones were both smaller
and less numerous. Therefore, these
authors propose that depending on the
context (e.g. the Myc levels within the
affected tissue), cell competition either
promotes or suppresses tumor growth.
The discovery of dMyc as a target
gene of Yki significantly advances
our understanding of the Hippo tumor
suppressor pathway, but the story
becomes even more exciting.
Neto-Silva and colleagues [5] noticed
that Yki protein levels were higher in
cells with reduced dMyc function.
Conversely, overexpression of dMyc
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Figure 1. Negative feedback loop involving the growth promoters Yki and dMyc.
dMyc is transcriptionally induced by Yki/Sd. The proto-oncoprotein dMyc keeps Yki levels in
check, thereby limiting its own expression. The Hippo pathway controls Yki activity by coun-
tering its nuclear translocation. Thus, Hippo signaling and the negative feedback mediated by
dMyc cooperate to prevent unrestricted growth caused by nuclear Yki.
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transcriptional and post-transcriptional
mechanisms appear to contribute
to the regulation of Yki in response
to altered dMyc levels (although
the experiments do not rule out
the involvement of a microRNA that
destabilizes yki mRNA). Importantly,
the increase in Yki protein upon low
dMyc activity did not change Yki’s
subcellular localization — the excess
Yki protein was predominantly
cytoplasmic. Consistently, reducing
dMyc levels was not sufficient to
induce Yki target genes.
Overexpression of dMyc, on the
other hand, decreased the induction
of Yki target genes. These findings are
consistent with a regulatory feedback
mechanism: Yki-dependent
transcription results in dMyc
expression; dMyc in turn
downregulates the amount of Yki.
Such negative feedback regulation
could ensure that Yki-induced growth
does not go awry.
Thus, Yki activity is kept in check in at
least two different ways (Figure 1): its
subcellular localization is regulated by
(phosphorylation-dependent and
phosphorylation-independent)
cytoplasmic retention mediated by
Hippo signaling [2,10,11], and itsprotein concentration is controlled by
dMyc [5]. This model predicts that, in
mutants preventing the
phosphorylation of Yki, a reduction in
dMyc levels should result in larger
amounts of Yki protein that is no longer
retained in the cytoplasm, which
is exactly what Neto-Silva and
colleagues [5] observed in their
experiments. Furthermore, disabling
the negative feedback should unearth
the combined growth potentials of Yki
and dMyc. Although the constant
supply of Yki from a transgene does
not abolish its post-transcriptional
containment, it may override the
negative regulation. In fact,
co-overexpression of dMyc and
Yki significantly enhanced growth.
In addition, the negative feedback
may also explain the reported
dMyc-induced cell-autonomous
apoptosis [8,12]. As high levels of dMyc
reduce cellular Yki concentration, less
Yki will be available in the nucleus to
induce Diap1 expression. The shortage
in Diap1 in turn renders the cells
susceptible to apoptosis. In keeping
with this notion, apoptosis was
reduced in dMyc-overexpressing cells
concomitantly mutant for Hippo
signaling (thus having more
nuclear Yki). Thus, the negativefeedback may also act as a safeguard
mechanism to restrict the growth
potential of cells with abnormally high
Myc levels.
The proposed growth-regulatory
circuit involving Yki and dMyc not only
integrates the activities of two potent
growth promoters but also provides
a means to balance growth. dMyc,
induced by nuclear Yki, ensures that
Yki does not accumulate in the cell,
thus restricting nuclear Yki in concert
with the Hippo signaling pathway,
which imposes control on Yki’s
subcellular localization. Since Yki is
such a potent growth inducer (by
inhibiting apoptosis, driving cell-cycle
progression and promoting cellular
growth), it is conceivable that its
activity is confined by different
mechanisms acting in parallel. The
negative feedback by dMyc is, at least
to some extent, bypassed by
overexpression of Yki. Interestingly,
overexpression of YAP, themammalian
homolog of Yki, also induced the
expression of c-Myc and resulted in
liver cancer resembling hepatocellular
carcinoma in mice [13], and YAP
overexpression is common in a variety
of solid tumors [2,14]. However, it
remains to be determined whether the
regulatory relationship between YAP
and Myc also exists in mammals.
Furthermore, it will be of great
importance to identify the mechanism
by which Myc controls the expression
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